Antithrombotic therapy in peripheral vascular disease.
作者信息
Makin Andrew J, Silverman Stanley H, Lip Gregory Y H
出版信息
BMJ. 2002 Nov 9;325(7372):1101-4. doi: 10.1136/bmj.325.7372.1101.
Abstract
摘要
相似文献
1
Antithrombotic therapy in peripheral vascular disease.
BMJ. 2002 Nov 9;325(7372):1101-4. doi: 10.1136/bmj.325.7372.1101.
2
Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
J Vasc Surg. 2006 Dec;44(6):1247-53. doi: 10.1016/j.jvs.2006.07.044.
3
Medical treatment of peripheral arterial disease and claudication.
N Engl J Med. 2001 May 24;344(21):1608-21. doi: 10.1056/NEJM200105243442108.
4
Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
Catheter Cardiovasc Interv. 2006 Nov;68(5):793-8. doi: 10.1002/ccd.20893.
5
TASC II section F on revascularization in PAD.
J Endovasc Ther. 2007 Oct;14(5):743-4. doi: 10.1177/152660280701400520.
6
TASC II section F on revascularization: commentary from an interventionist's point of view.
J Endovasc Ther. 2007 Oct;14(5):734-42. doi: 10.1177/152660280701400519.
7
Inter-society consensus for the management of peripheral arterial disease.
Int Angiol. 2007 Jun;26(2):81-157.
8
Antithrombotic therapy in peripheral artery disease.
Vasc Med. 2016 Apr;21(2):156-69. doi: 10.1177/1358863X15622987. Epub 2016 Jan 28.
9
Clinical practice. Intermittent claudication.
N Engl J Med. 2007 Mar 22;356(12):1241-50. doi: 10.1056/NEJMcp064483.
10
Management of peripheral arterial disease and intermittent claudication.
J Am Board Fam Pract. 2001 Nov-Dec;14(6):443-50.
Zotero 插件